As a dedicated partner empowering global biotechnology and pharmaceutical assets, Protheragen specializes in facilitating strategic transactions and high-impact collaborations. We are committed to bridging the gap between innovative science and commercial success.

We invite you to explore our press releases to learn how we drive industry growth and breakthroughs through our extensive global network and deep sector expertise.

Apr 28, 2026
Protheragen and Quarkmed Announce Strategic Partnership to Bring Global Resources and Overseas Clients to Quarkmed
Read more >

Apr 27, 2026
Protheragen and Zencore Biologics Forge Strategic Partnership: “Go-Global + Manufacturing” Synergy to Empower Global Translation of Chinese Biotech Innovations
Read more >

Apr 27, 2026
Protheragen and Clinical Service Center (CSC) Announce Strategic Partnership to Establish “Project + Platform” Cross-Border Synergy Model
Read more >

Apr 23, 2026
Meet Protheragen at ChinaBio® Partnering Forum 2026
Read more >

Apr 17, 2026
Medicilon and Protheragen Forge Strategic Partnership to Build a Collaborative “Project + Platform” Model
Read more >

Mar 26, 2026
Fostering Global Biotech Partnerships: Protheragen at BIOCHINA 2026
Read more >

Mar 11, 2026
Protheragen Joins VentriLinks as a Founding Strategic Partner to Accelerate Early-Stage Biotech Innovation
Read more >

Mar 05, 2026
Protheragen to Bridge Innovation at BIOCHINA 2026
Read more >

Jan 19, 2026
Protheragen Drives Global Strategic Collaborations During JPM Week 2026
Read more >

Nov 25, 2025
Protheragen Congratulates Serpentide on Its Partnership with Novo Nordisk
Read more >